Literature DB >> 1481904

Acute endoneurial ischemia induced by epineurial endothelin in the rat sciatic nerve.

D W Zochodne1, L T Ho, P M Gross.   

Abstract

Endothelin (ET) is a potent vasoconstrictor peptide that may have pathophysiological roles in the microcirculation of the peripheral nervous system. We examined the local action of epineurial ET-1 on sciatic endoneurial blood flow using serial hydrogen clearance measurements in anesthetized, paralyzed, and ventilated Sprague-Dawley rats. In separate rats, we made serial measurements of sciatic motor multifiber conduction before and then after application of epineurial ET (saline on contralateral nerve) 2 and 24 h and 4 and 7 days later. Epineurial bathing solutions of ET increased microvascular resistance and reduced local endoneurial blood flow in a dose-responsive fashion with a half-maximum effective concentration of 10(-8) M. Maximum vasoconstriction at 10(-6) M ET was associated with a fall in endoneurial blood flow from 18.7 (pre-ET) to 7.2 ml x 100 g-1 x min-1. Epineurial norepinephrine (10(-7) to 10(-10) M) also resulted in vasoconstriction, but of lesser degree. Pretreatment with intraperitoneal nimodipine, a dihydropyridine Ca2+ channel antagonist, but not phentolamine, prevented the vasoconstrictive action of ET. Three of eight animals developed temporary but complete axonal conduction block at the site of ET administration (10(-5) M) and four others had partial conduction block. Contralateral saline-treated sciatic fibers were unaffected. Local ET action on extrinsic epineurial microvessels results in reversible ischemia of the underlying endoneurium that may be associated with conduction block. ET's action is more potent than norepinephrine and appears dependent on L-type voltage-gated Ca2+ channels.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1481904     DOI: 10.1152/ajpheart.1992.263.6.H1806

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

Review 1.  Role of endothelin in diabetic vascular complications.

Authors:  H C Lam
Journal:  Endocrine       Date:  2001-04       Impact factor: 3.633

2.  Opening remarks.

Authors:  Kazuyoshi Hirota; Katsuo Terui
Journal:  J Anesth       Date:  2007-11-01       Impact factor: 2.078

3.  Activation of endothelin A receptors contributes to impaired responsiveness of renal mechanosensory nerves in congestive heart failure.

Authors:  Ulla C Kopp; Michael Z Cicha; Susan Y Jones
Journal:  Can J Physiol Pharmacol       Date:  2010-06       Impact factor: 2.273

4.  Reduction-oxidation (Redox) and vascular tissue level of homocyst(e)ine in human coronary atherosclerotic lesions and role in extracellular matrix remodeling and vascular tone.

Authors:  S C Tyagi; L M Smiley; V S Mujumdar; B Clonts; J L Parker
Journal:  Mol Cell Biochem       Date:  1998-04       Impact factor: 3.396

5.  Vasoreactivity to prostaglandins of rat peripheral nerve.

Authors:  M Kihara; P A Low
Journal:  J Physiol       Date:  1995-04-15       Impact factor: 5.182

6.  Transcriptomic Analysis of Human Mesenchymal Stem Cell Therapy in Incontinent Rat Injured Urethra.

Authors:  Zhina Sadeghi; Jonathan D Kenyon; Brian Richardson; Ahmad O Khalifa; Michael Cartwright; Britt Conroy; Arnold Caplan; Mark J Cameron; Adonis Hijaz
Journal:  Tissue Eng Part A       Date:  2020-07-02       Impact factor: 3.845

7.  The potential contribution of endothelin-1 to neurovascular abnormalities in streptozotocin-diabetic rats.

Authors:  N E Cameron; K C Dines; M A Cotter
Journal:  Diabetologia       Date:  1994-12       Impact factor: 10.122

8.  Contralateral paw sensitization following injection of endothelin-1: effects of local anesthetics differentiate peripheral and central processes.

Authors:  A Khodorova; G R Strichartz
Journal:  Neuroscience       Date:  2010-01-20       Impact factor: 3.590

Review 9.  Endothelin receptors and pain.

Authors:  Alla Khodorova; Jean-Pierre Montmayeur; Gary Strichartz
Journal:  J Pain       Date:  2009-01       Impact factor: 5.820

10.  Endothelin-1 as a neuropeptide: neurotransmitter or neurovascular effects?

Authors:  Michael R Dashwood; Andrzej Loesch
Journal:  J Cell Commun Signal       Date:  2009-10-22       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.